Exploring Predictive and Prognostic Biomarkers in People with Cancer.

Monash Health0 个研究点目标入组 500 人开始时间: 2023年8月8日最近更新: 2024年7月15日

适应症

试验速览

暂无简介。

•Monash Health patients will be included in this study if they meet all of the following inclusion criteria:
•1. Aged 18 years or older
•2. Histological or cytological diagnosis of solid organ cancer
•3. Able to be accessible for follow-up and data collection
•4. Able to provide written, voluntary and informed consent
•5. Able to undergo core needle biopsy of metastases (patients must have a lesion which is deemed medically safe to biopsy as part of routine standard of care)
•6. Able to undergo collection of blood specimens during treatment. ; Monash Health patients will be included in this study if they meet all of the following inclusion criteria:
•1. Aged 18 years or older
•2. Histological or cytological diagnosis of solid organ cancer
•3. Able to be accessible for follow-up and data collection
•4. Able to provide written, voluntary and informed consent
•5. Able to undergo core needle biopsy of metastases (patients must have a lesion which is deemed medically safe to biopsy as part of routine standard of care)
•6. Able to undergo collection of blood specimens during treatment.

•Monash Health patients will be excluded from this study if they meet any of the following exclusion criteria:
•1. Unable to be accessible for follow-up and data collection
•2. Medical or psychiatric condition or occupational responsibilities that may preclude compliance with the protocol.
•; Monash Health patients will be excluded from this study if they meet any of the following exclusion criteria:
•1. Unable to be accessible for follow-up and data collection
•2. Medical or psychiatric condition or occupational responsibilities that may preclude compliance with the protocol.

发起方